Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Bailey

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Transplantation|April 13, 2022
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine ResponseAndrew H Karaba, Trevor S Johnston, Tihitina Y Aytenfisu, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Transplantation|January 27, 2022
Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant RecipientsAndrew H Karaba, Xianming Zhu, Sarah E Benner, et al.
Journal of Virology|June 16, 2006
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsJustin R Bailey, Ahmad R Sedaghat, Tara Kieffer, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Frontiers in Immunology|November 29, 2023
Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapiesJenny M Lee, Alexis Figueroa, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2022
Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant RecipientsAndrew H Karaba, Weiqiang Zhou, Shuai Li, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant RecipientsAndrew H Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2021
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipientsAndrew H Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2023
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine doseWilliam A Werbel, Andrew H Karaba, Teresa Po-Yu Chiang, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Transplantation|April 13, 2022
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine ResponseAndrew H Karaba, Trevor S Johnston, Tihitina Y Aytenfisu, et al.
Hepatology (Baltimore, Md.)|September 20, 2016
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in miceZhen-Yong Keck, Yong Wang, Patrick Lau, et al.
Transplantation|January 27, 2022
Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant RecipientsAndrew H Karaba, Xianming Zhu, Sarah E Benner, et al.
Journal of Virology|June 16, 2006
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsJustin R Bailey, Ahmad R Sedaghat, Tara Kieffer, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Frontiers in Immunology|November 29, 2023
Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapiesJenny M Lee, Alexis Figueroa, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2022
Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant RecipientsAndrew H Karaba, Weiqiang Zhou, Shuai Li, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant RecipientsAndrew H Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2021
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipientsAndrew H Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 26, 2023
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine doseWilliam A Werbel, Andrew H Karaba, Teresa Po-Yu Chiang, et al.
Pageof 9